您当前的位置：
首页 >
文章列表页 >
Mechanism of Modified Shengjiangsan in Improving Diabetic Kidney Disease by Activating Mitochondrial Autophagy Based on PINK1/Parkin Signaling Pathway
更新时间：2025-05-16

    • Mechanism of Modified Shengjiangsan in Improving Diabetic Kidney Disease by Activating Mitochondrial Autophagy Based on PINK1/Parkin Signaling Pathway

    • “The latest research found that Jiawei Shengjiang Powder improved diabetes nephropathy by activating mitochondrial autophagy, providing a new scheme for renal protection.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 12, Pages: 121-128(2025)

    • DOI：10.13422/j.cnki.syfjx.20250601    

      CLC： R285;R259;R289

    • Received：13 January 2025，

      Accepted：24 March 2025，

      Published Online：26 March 2025，

      Published：20 June 2025

    移动端阅览

  • LI Jiaxin,ZHOU Liya,ZHANG Yishuo,et al.Mechanism of Modified Shengjiangsan in Improving Diabetic Kidney Disease by Activating Mitochondrial Autophagy Based on PINK1/Parkin Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(12):121-128. DOI： 10.13422/j.cnki.syfjx.20250601.

  •  
  •  

0

Views

45

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Zhenzhu Tiaozhi Capsules Reduce Renal Lipid Deposition and Inflammation in Mouse Model of Diabetic Kidney Disease via SCAP-SREBP-1c/NLRP3 Signaling Pathway
Effect of Shenkang Injection on Podocyte Apoptosis and GRP78/CHOP Signaling Pathway in db/db Mice with Diabetic Kidney Disease Based on Endoplasmic Reticulum Stress
Effect of Bushen Huoxue Prescription in Regulating PINK1/Parkin Pathway in Rat Model of Premature Ovarian Failure
Shenqi Dihuang Decoction Improves Renal Function in Mouse Model of Diabetic Kidney Disease by Inhibiting Arachidonic Acid-related Ferroptosis Via ACSL4/LPCAT3/ALOX15 Axis
Mechanism of Mitochondrial Autophagy and Intervention of Traditional Chinese Medicine in Renal Fibrosis： A Review

Related Author

ZHANG Tao
TAO Jie
ZHANG Yinghui
YANG Yiqi
RONG Xianglu
GUO Jiao
CAI Yanmo
WANG Sitong

Related Institution

Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine， Guangdong Pharmaceutical University
School of Traditional Chinese Medicine， Beijing University of Chinese Medicine
Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences
School of Integrated Chinese and Western Medicine， School of Chinese Medicine， The Second Affiliated Hospital， School of Medicine， and Hunan Provincial Key Laboratory of Translational Medicine in Traditional Chinese Medicine Formula-Syndrome Research， Hunan University of Chinese Medicine
The First Affiliated Hospital of Hunan University of Chinese Medicine
0